PT949258E - Acido alfa-liponico em forma cristalina - Google Patents

Acido alfa-liponico em forma cristalina

Info

Publication number
PT949258E
PT949258E PT99104155T PT99104155T PT949258E PT 949258 E PT949258 E PT 949258E PT 99104155 T PT99104155 T PT 99104155T PT 99104155 T PT99104155 T PT 99104155T PT 949258 E PT949258 E PT 949258E
Authority
PT
Portugal
Prior art keywords
alpha
crystalline form
liponic acid
enantiomer
acid
Prior art date
Application number
PT99104155T
Other languages
English (en)
Portuguese (pt)
Inventor
Beisswenger Dr Thomas
Karl-Friedrich Landgraf
Matthias Rischer
Gunter Laban
Eberhard Oestreich
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of PT949258E publication Critical patent/PT949258E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Seasonings (AREA)
PT99104155T 1998-03-11 1999-03-02 Acido alfa-liponico em forma cristalina PT949258E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19810336A DE19810336A1 (de) 1998-03-11 1998-03-11 Alpha-Liponsäure mit neuartiger Modifikation
US09/074,645 US5994393A (en) 1998-03-11 1998-05-08 Alpha-lipoic acid with novel modification

Publications (1)

Publication Number Publication Date
PT949258E true PT949258E (pt) 2002-04-29

Family

ID=26044524

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99104155T PT949258E (pt) 1998-03-11 1999-03-02 Acido alfa-liponico em forma cristalina

Country Status (10)

Country Link
US (1) US5994393A (en, 2012)
EP (1) EP0949258B1 (en, 2012)
AT (1) ATE207914T1 (en, 2012)
CA (1) CA2265276C (en, 2012)
CY (1) CY1106435T1 (en, 2012)
DE (2) DE19810336A1 (en, 2012)
DK (1) DK0949258T3 (en, 2012)
ES (1) ES2164474T3 (en, 2012)
IN (1) IN186598B (en, 2012)
PT (1) PT949258E (en, 2012)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19834608A1 (de) * 1998-07-31 2000-02-03 Basf Ag Kristallmodifikation der Liponsäure
ATE320833T1 (de) * 2000-06-06 2006-04-15 Verwendung von einem liponsaüren -(r)- enantiomeren in kosmetika und dermatologie
DE10151764A1 (de) * 2001-10-19 2003-05-08 Basf Ag Kombination von Liponsäure und Glutamin in Lebens- und Arzneimitteln
US20090176864A1 (en) * 2004-11-24 2009-07-09 Hill's Pet Nutrition, Inc. Methods For Improving Hepatic and Immune Function In An Animal
EP1817058B1 (en) * 2004-11-24 2015-09-02 Hill's Pet Nutrition, Inc. Composition for use in improving liver clearance of xenobiotic substances in an animal
AU2005322887B2 (en) 2004-12-30 2010-03-11 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
US8252742B2 (en) 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
JP2012510511A (ja) * 2008-12-01 2012-05-10 インヴアスク セラピューテイックス インコーポレイテッド レニン−アンジオテンシン−アルドステロン系阻害剤及びリポ酸化合物を含有する組成物、並びに、レニン−アンジオテンシン−アルドステロン系に関連した疾患の治療のためのそれらの使用
CN108484570B (zh) * 2018-05-15 2021-05-04 苏州富士莱医药股份有限公司 一种制备硫辛酸颗粒的方法及设备

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE163849T1 (de) * 1989-11-09 1998-03-15 Asta Medica Ag Arzneimittel enthaltend als wirkstoff r-alpha- liponsäure oder s-alpha-liponsäure
DE4218572A1 (de) * 1992-06-05 1993-12-09 Asta Medica Ag Synergistische Kombination von Arzneimitteln enthaltend als Wirkstoff alpha-Liponsäure, Dihydroliponsäure, deren Metaboliten sowie die oxidierten und reduzierten Enantiomere der alpha-Liponsäure wie die R-alpha-Liponsäure oder S-alpha-Liponsäure sowie Metaboliten der alpha-Liponsäure mit den Vitaminen A, B1-6, B12, C und E
DE4235912C2 (de) * 1992-10-23 2002-12-05 Viatris Gmbh Verfahren zur Herstellung kristalliner Thioctsäure und deren Verwendung
DE4433764A1 (de) * 1994-09-22 1996-03-28 Asta Medica Ag Darreichungsformen enthaltend alpha-Liponsäure, feste Salze von R-Thioctsäure mit verbesserter Freisetzung und Bioverfügbarkeit

Also Published As

Publication number Publication date
CA2265276C (en) 2009-09-08
CY1106435T1 (el) 2011-04-06
DK0949258T3 (da) 2002-01-28
CA2265276A1 (en) 1999-09-11
DE59900364D1 (de) 2001-12-06
EP0949258A1 (de) 1999-10-13
ES2164474T3 (es) 2002-02-16
ATE207914T1 (de) 2001-11-15
DE19810336A1 (de) 1999-09-23
US5994393A (en) 1999-11-30
IN186598B (en, 2012) 2001-10-06
EP0949258B1 (de) 2001-10-31

Similar Documents

Publication Publication Date Title
AU589155B2 (en) Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido) azabicycloalkanes
PT949258E (pt) Acido alfa-liponico em forma cristalina
WO2004011453A3 (en) Method for preparing 3-halo-4,5-dihydro-1h-pyrazoles
CA2349227A1 (en) Substituted 2-phenylbenzimidazoles, the production thereof and their use
WO1999030548A3 (en) Method for the preparation of citalopram
HUP0500084A3 (en) Encapsulation by coating with a mixture of lipids and hydrophobic, high melting point compounds
AU1704201A (en) Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
NZ510070A (en) Crystalline forms of EtO2 C-CH2 -(R)Cgl-Aze-Pab-OH
MXPA03011770A (es) Proceso para la preparacion de citalopram racemico y/o s- o r-citalopram por separacion de una mezcla de r- y s- citalopram.
CA2333008A1 (en) New heterocyclically substituted amides, their production and their use
GB8320203D0 (en) Anti-viral compositions
CA2503154A1 (en) A new crystalline form of the sodium salt of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid
GR3032793T3 (en) Preparation of lithiumhexafluorometallates
ZA200207675B (en) Novel crystal form of pyrrolidylthiocarbapenem derivative.
TW200512337A (en) Carrier band material and carrier band
BR0107743B1 (pt) processo para manufatura de grade positiva fina para baterias de chumbo ácidas e grade.
ATE35413T1 (de) Cephalosporinverbindungen und ihre herstellung.
IE45109L (en) N-2-imidazolidinylidene-benzeneamine
PT1277750E (pt) Hidratos e cristais de um composto de acido neuraminico
FR2782517B1 (fr) Procede de fabrication d'hexafluorophosphate de lithium
EP0960879A3 (en) Improved process for the preparation of 5-aminotetrazole
BR9808637A (pt) Compostos e método de preparação de ácidos 4-fenil-4 cianociclohexanóico
EP0954974A3 (en) Novel leavening acid composition
AU4411089A (en) Benzothiadiazepine derivatives
MA23268A1 (fr) Procede de preparation de composes azacyliques heterocycliques utiles comme antagonistes des recepteurs d'natagonisne ii.